Karberg Sascha
Cell. 2009 Aug 7;138(3):413-5. doi: 10.1016/j.cell.2009.07.026.
The global financial crisis has hit biotech companies hard both in the US and Europe as venture capital dries up. Finding new sources of long-term financing for translating research into new therapeutics will be essential for maintaining innovation and new drug development by biotech companies.
全球金融危机对美国和欧洲的生物技术公司造成了沉重打击,因为风险投资枯竭。为将研究转化为新疗法找到新的长期融资来源,对于生物技术公司维持创新和新药开发至关重要。